8dwy
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 8dwy is ON HOLD Authors: Adams, L.J., Fremont, D.H., Center for Structural Genomics of Infectious Diseases (CSGID) Description: Chikungunya VLP in ...) |
|||
| (3 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Chikungunya VLP in complex with neutralizing Fab CHK-265 (asymmetric unit)== | |
| + | <StructureSection load='8dwy' size='340' side='right'caption='[[8dwy]], [[Resolution|resolution]] 3.18Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[8dwy]] is a 20 chain structure with sequence from [https://en.wikipedia.org/wiki/Chikungunya_virus_strain_Senegal_37997 Chikungunya virus strain Senegal 37997] and [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8DWY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8DWY FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.18Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8dwy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8dwy OCA], [https://pdbe.org/8dwy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8dwy RCSB], [https://www.ebi.ac.uk/pdbsum/8dwy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8dwy ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes epidemics of acute and chronic musculoskeletal disease. Here, we analyzed the human B cell response to a CHIKV-like particle-adjuvanted vaccine (PXVX0317) from samples obtained from a phase 2 clinical trial in humans (NCT03483961). Immunization with PXVX0317 induced high levels of neutralizing antibody in serum against CHIKV and circulating antigen-specific B cells up to 6 months after immunization. Monoclonal antibodies (mAbs) generated from peripheral blood B cells of three PXVX0317-vaccinated individuals on day 57 after immunization potently neutralized CHIKV infection, and a subset of these inhibited multiple related arthritogenic alphaviruses. Epitope mapping and cryo-electron microscopy defined two broadly neutralizing mAbs that uniquely bind to the apex of the B domain of the E2 glycoprotein. These results demonstrate the inhibitory breadth and activity of the human B cell response induced by the PXVX0317 vaccine against CHIKV and potentially other related alphaviruses. | ||
| - | + | A chikungunya virus-like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans.,Raju S, Adams LJ, Earnest JT, Warfield K, Vang L, Crowe JE Jr, Fremont DH, Diamond MS Sci Transl Med. 2023 May 17;15(696):eade8273. doi: 10.1126/scitranslmed.ade8273. , Epub 2023 May 17. PMID:37196061<ref>PMID:37196061</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | [[Category: | + | </div> |
| - | [[Category: | + | <div class="pdbe-citations 8dwy" style="background-color:#fffaf0;"></div> |
| - | [[Category: Adams | + | == References == |
| - | [[Category: | + | <references/> |
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Chikungunya virus strain Senegal 37997]] | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Adams LJ]] | ||
| + | [[Category: Fremont DH]] | ||
Current revision
Chikungunya VLP in complex with neutralizing Fab CHK-265 (asymmetric unit)
| |||||||||||
